Download presentation
Presentation is loading. Please wait.
Published byMiles Hart Modified over 5 years ago
1
Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure
2
Heart Failure
3
Traditional Treatment for Acute Decompensated Heart Failure
4
Traditional Treatment for Acute Decompensated Heart Failure (cont)
5
Traditional Treatment for Acute Decompensated Heart Failure (cont)
6
Traditional Positive Inotropic Agents
7
Omecamtiv Mecarbil: A Novel Selective Cardiac Myosin Activator
8
Omecamtiv Mecarbil
9
Omecamtiv Mecarbil: Echocardiogram Changes in Healthy Volunteers
10
Omecamtiv Mecarbil: Echocardiographic Changes in Patients With Stable Heart Failure and LV Dysfunction
11
ATOMIC-AHF: Study Design Randomized, Double-blind, Placebo-controlled, Sequential Cohort Study
12
ATOMIC-AHF-Primary End Point: Dyspnea Response Paired Placebo
13
Safety Concerns
14
Supraventricular and Ventricular Tachyarrhythmias
15
COSMIC-HF: Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
16
References
17
Abbreviations
18
Abbreviations (cont)
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.